-
$EPZM Epizyme, Inc. SEC Filing: Form 4 http://www.sec.gov/Archives/edgar/data/1571498/000089924320003376/xslF345X03/doc4.xml … -
$EPZM: New Insider Filing on Chief Financial Officer PAOLO TOMBESI: http://insideri.com/1707648_000089924320003366_0000899243-20-003366 … -
11,688 shares acquired by Ros Matthew (See Remarks), reported in a new form 4 filed with the SEC
$EPZM https://newsfilter.io/articles/4-form---statement-of-changes-in-beneficial-ownership-of-securities---epizyme-inc-0001571498-issuer-d5d00d43daa13572445bf5a936e7eb81 … -
$EPZM watch long over todays highs pic.twitter.com/QpyNZV97cB
-
Epizyme (EPZM) Dips More Than Broader Markets: What You Should Know https://finance.yahoo.com/news/epizyme-epzm-dips-more-broader-225010480.html?soc_src=community&soc_trk=tw … via
@YahooFinance$EPZM -
-
BUY
$ZYNE and$EPZM everyone in biotechs should have these on close watch. https://www.streetinsider.com/dr/news.php?id=16403349&gfv=1 … -
Bought
$EPZM. 175% long by 31% short. 34% long Health Care, 29% long Technology, 14% long Finance, 14% long Consumer Services. https://www.techtrader.ai/wall/?date=1580493871&post=11495&utm_medium=twitter&utm_campaign=techtraderai …#AI#AutonomousTradingpic.twitter.com/m0M77jKrKt
-
-
-
-
$EPZM - Epizyme's Tazemetostat Is Approved, And Other News: The Good, Bad, And Ugly Of Biopharma. https://seekingalpha.com/article/4320290-epizymes-tazemetostat-is-approved-and-news-good-bad-and-ugly-of-biopharma?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated …#finance#trading#economy -
$EPZM

LETS GOO -
$EPZM Bounce off support after FDA approval sell off? pic.twitter.com/t4sVeMNMCY
-
Epizyme Announces FDA Advisory Committee Meeting to Review Tazemetostat for the Treatment of Patients with Epithelioid Sarcoma
$EPZM https://newsfilter.io/articles/epizyme-announces-fda-advisory-committee-meeting-to-review-tazemetostat-for-the-treatment-of-patient-f8b9310953891635ed434a63fb5f5c66 … -
Epizyme Announces FDA Committee Review of Tazemetostat NDA
$GSK$RHHBY$ALKS$EPZM https://newsfilter.io/articles/epizyme-announces-fda-committee-review-of-tazemetostat-nda-f9b303a6cb2cc7ce1a2f45095a652aa7 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.